Skip to main content
. 2016 Jun 15;11(6):e0156852. doi: 10.1371/journal.pone.0156852

Fig 6. Bethanechol differentially affects GIP and GLP-1 responses in humans with NGT, IGT, and T2DM.

Fig 6

Selected data from Fig 3 (-15 to 30 min) are expanded to emphasize differential GLP-1 (panels A-C) and GIP (panels D-F) responses to the 150 mg dose of bethanechol.